Speaker

BAS21 | Speaker: Dr Ralf Angermund
Dr Ralf Angermund
Therapeutic Area Director Hematology & Solid Tumors
Janssen-Cilag Germany

1984 - 1991 Medical Schoo University Düsseldorf
1991 - 1999 Medical Training (Fellowship) Philippusstift Essen & University Medical School Essen, West German Cancer Centre
1998 Board Certification Internal Medicine
1999 Board Certification Hematology & Medical Oncology
1999 - 2004 Head Clinical Affairs Oncology Janssen-Cilag/Ortho Biotech Germany
2004-2007 Therapeutic Area Director Oncology Janssen-Cilag Germany
2007-2012 European Medical Affairs Director Hematology Janssen-Cilag Europe
2012-2019 Therapeutic Area Director Hematology Janssen-Cilag Germany
since 2019 Therapeutic Area Director Hematology & Solid Tumors Janssen-Cilag Germany

 

11:50—12:10

AI applications in action for better and personalized therapies: what do we learn from good examples?

  • Dr Ralf Angermund, Therapeutic Area Director Hematology & Solid Tumors, Janssen-Cilag Germany

  • Prof Dr Thomas Neumuth, CTO, Universität Leipzig, ICCAS

  • Laura Wamprecht, Managing Director, Flying Health